Objective. To develop and validate a risk score [global APS score (GAPSS)] derived from the
combination of independent risk for thrombosis and pregnancy loss (PL), taking into account …

Objective Recently, our group conceived a risk score for clinical manifestations of APS (the
global APS score, or GAPSS) that takes into account the combination of independent …

Objective. The aim of this study was to evaluate the clinical relevance of the global APS
score (GAPSS) in a cohort of primary APS patients. Methods. This study included 62 …

Objective. To investigate the validity of the global APS score (GAPSS) to predict thrombosis
in patients with autoimmune diseases. Methods. This prospective cohort study included …

Objective To define the antiphospholipid score (aPL‐S) by testing multiple antiphospholipid
antibodies (aPL) and to evaluate its efficacy for the diagnosis of antiphospholipid syndrome …

Objectives To assess whether patients with antiphospholipid syndrome (APS) and history of
recurrent thrombosis have higher levels of adjusted Global AntiphosPholipid Syndrome …

Objective. Antiphospholipid antibodies (aPL) are major risk factors for thrombosis. Other
clinical factors exist in antiphospholipid syndrome (APS) patients which may have an …

Objectives: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Objective: To analyse antiphospholipid (aPL) antibody-positive patients using the 2006
revised antiphospholipid syndrome (APS) classification criteria. Methods: A descriptive study …

Objective. To identify the risk factors associated with pregnancy failure in patients with APS
treated with conventional therapy. Methods. A multicentre, case–control study was …